Impel Pharmaceuticals INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.6Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
6,971clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $1.7M
2023 $839K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $1.8M
Family Medicine $94K
Family $88K
Internal Medicine $84K
Nurse Practitioner $63K
Neurology With Special Qualifications In Child Neurology $55K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $115,363.12
Stephen Landy Tupelo, MS Neurology (Psychiatry & Neurology) $91,857.71
Clinton Lauritsen Philadelphia, PA Neurology (Psychiatry & Neurology) $70,944.06
Hossein Ansari San Diego, CA Neurology (Psychiatry & Neurology) $59,465.84
Eric Eross Phoenix, AZ Neurology (Psychiatry & Neurology) $53,688.40
Jack Schim Carlsbad, CA Neurology (Psychiatry & Neurology) $50,671.37
Nicolas Saikali Amherst, NY Neurology (Psychiatry & Neurology) $43,708.38
Frank Berenson Atlanta, GA Neurology (Psychiatry & Neurology) $43,405.72
Shivang Joshi Westborough, MA Neurology (Psychiatry & Neurology) $41,041.53
Eric Baron Cleveland, OH Neurology (Psychiatry & Neurology) $38,690.79

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.